Erich Bluhmki und Stefan Hantel - Info zur Person

(1 - 13 von 14

)

Rationale, design, and baseline OPUS Würzburgopus.bibliothek.uni-wuerzburg.de › ...

opus.bibliothek.uni-wuerzburg.de

Bernard Zinman, Silvio E. Inzucchi, John M. Lachin, Christoph Wanner, Roberto Ferrari, David Fitchett, Erich Bluhmki, Stefan Hantel, Joan ...

@article{ZinmanInzucchiLachinetal.2014, author = {Bernard Zinman ...

opus.bibliothek.uni-wuerzburg.de

... David Fitchett and Erich Bluhmki and Stefan Hantel and Joan Kempthorne-Rawson and Jennifer Newman and Odd Erik Johansen and Hans-Juergen Woerle ...

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2...

www.scienceopen.com

Authors: Bernard Zinman, Christoph Wanner, John M. Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, ...

Diabetes drug reduces risk of heart failure and may prevent it, study...

www.sciencedaily.com

Bernard Zinman, Christoph Wanner, John M. Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J. Woerle, Uli C. Broedl, Silvio E. Inzucchi. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. New England Journal of ...

OPUS Würzburg | Rationale, design, and baseline characteristics of a...

opus.bibliothek.uni-wuerzburg.de

... and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME (TM)). Bernard Zinman, Silvio E. Inzucchi, John M. Lachin, Christoph Wanner, Roberto Ferrari, David Fitchett, Erich Bluhmki, Stefan Hantel, Joan Kempthorne-Rawson, ...

Seguridad cardiovascular de la empaglifozina en la diabetes mellitus...

secardiologia.es

Bernard Zinman, Christoph Wanner, John M. Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd ...

Alle Infos zum Namen "Erich Bluhmki"

GMS | 54. Jahrestagung der Deutschen Gesellschaft für Medizinische...

www.egms.de

Authors Stefan Hantel - Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach Erich Bluhmki - Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach

CoCited Articles Page - CoCitescocites.com › coCitedArticles

cocites.com

Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans ...

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2...

researchnow.flinders.edu.au

Bernard Zinman, Christoph Wanner, John Lachin, D Fitchett, Erich Bluhmki, Stefan Hantel, M Mattheus, Theresa Devins, Odd Johansen, H J Woerle, Joseph ...

Altmetric – How Does Empagliflozin Reduce Cardiovascular Mortality?...

diabetes.altmetric.com

... Ele Ferrannini, Martin Schumacher, Claudia Schmoor, Kristin Ohneberg, Odd Erik Johansen, Jyothis T. George, Stefan Hantel, Erich Bluhmki, John M. Lachin.

Module Preview

cme.hs.pitt.edu

... M.D., Erich Bluhmki, Ph.D., Stefan Hantel, Ph.D., Michaela Mattheus, Dipl. Biomath., Theresa Devins, Dr.P.H., Odd Erik Johansen, M.D., Ph.D., Hans J. Woerle, ...

Empagliflozin and Cardiovascular Outcomes in Patients with ...

my.americanheart.org

Michael's Hosp, Toronto, ON, Canada; Erich Bluhmki, Stefan Hantel, Boehringer Ingelheim Pharma. GmbH & Co. KG, Biberach, Germany; Michaela Mattheus, ...

Improved cardiovascular outcomes with empagliflozin treatment |...

www.cardio-debate.com

1. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. Bernard Zinman, M.D., Christoph Wanner, M.D., John M. Lachin, Sc.D., David Fitchett, M.D., Erich Bluhmki, Ph.D., Stefan Hantel, Ph.D., Michaela Mattheus, Dipl. Biomath., Theresa Devins, Dr.P.H., Odd Erik Johansen, M.D., Ph.D., ...

Verwandte Suchanfragen zu Erich Bluhmki

Erik Johansen
Werner Hacke
Michaela Mattheus

Thomas Brott
Dietmar Schneider
Stefan Hantel

Geoffrey Donnan
Christoph Wanner
Geoff Cohen

Personen
Vorname "Erich" (17990)
Name "Bluhmki" (14)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Erich Bluhmki und Stefan Hantel Person-Info